U.S. Government Allocates $3.2 Billion for COVID-19 Antiviral Pills

Department of Health & Human Services

The Department of Health and Human Services will invest $3.2 billion to develop and manufacture COVID-19 antiviral medicines, it announced Thursday.

The initiative, funded as part of the American Rescue Plan, is designed to accelerate research into antivirals as well as build platforms for urgent response to future viral threats, the Department of Health and Human Services (HHS) said in a statement Thursday. Specifically, the plan expands antiviral clinical trials, forms partnerships between health agencies and pharmaceutical companies, and funds “drug discovery groups” tasked with innovating new antiviral medicines.

“New antivirals that prevent serious COVID-19 illness and death, especially oral drugs that could be taken at home early in the course of disease, would be powerful tools for battling the pandemic and saving lives,” said chief medical adviser Dr. Anthony Fauci in the statement.

Read More

Ten Percent of Migrant Minors Held in San Diego Convention Center Test Positive for COVID-19

San Diego Convention Center

Of the more than 700 unaccompanied migrant minors who were transported to the San Diego Convention Center from Texas, roughly 10% have tested positive for COVID-19, according to multiple news reports citing health officials.

The Department of Health and Human Services reported on March 30 that 70 of these minors tested positive; none required hospitalization.

The San Diego Convention Center is currently holding 723 girls between the ages of 13 and 17 – all of whom were transferred from federal shelters in Texas.

Read More